VivoSeq
Other

Pulmonary Nodules

0

Pipeline Programs↗

4

Active Trials↗

0

Companies Involved↗

Pulmonary Nodules is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

67/100

Attrition Rate

13/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

8

clinical trials

Recruiting3 · 38%
Completed2 · 25%
Terminated1 · 13%
Unknown status1 · 13%
Not yet recruiting1 · 13%

Clinical Trials

Trial Activity

8 trials

Molecular Analysis of Endoscopic Cytology Samples Supernatant in Pulmonary Nodules
Recruiting·UUniversity Hospital, Toulouse·N/A·NCT05306912·60 enrolled
Multi-omics Detection Techniques for Differentiating Benign and Malignant Pulmonary Nodules
Recruiting·—·N/A·NCT07047573·150 enrolled
Postoperative EGFR-TKI Therapy forContralateral Pulmonary Nodules in Patients With EGFR-Mutant NSCLC（ARMOR2501）
Recruiting·SSun Yat-sen University·Phase 2·NCT06924398·32 enrolled
Self-driving Robotic-assisted Bronchoscopy for the Diagnosis of Peripheral Pulmonary Nodules
Not yet recruiting·SShanghai Chest Hospital·Preclinical·NCT06719687·30 enrolled
Intraoperative Imaging of Pulmonary Nodules by SGM-101
Completed·—·Phase 1·NCT04315467·10 enrolled
Intraoperative Imaging of Pulmonary Nodules by OTL38
Completed·UUniversity of Pennsylvania·Phase 1·NCT02602119·262 enrolled
ThoHSpEkt Thoracoscopic Ectomy of Radioactively Marked Pulmonary Nodules With Free-hand SPECT
Terminated·—·Phase 2·NCT02050724·11 enrolled
Dynamic Evolution of Pulmonary Nodules and Influence Factors of Its Clinical Decision-making
Unknown status·—·N/A·NCT04857333·1,800 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)